AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation
Authors: Lorenz, E Schwartz, DA Martin, PJ Gooley, T Lin, MT Chien, JW Hansen, JA Clark, JG
Citation: E. Lorenz et al., Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation, BIOL BLOOD, 7(7), 2001, pp. 384-387
Secondary failure of platelet recovery after hematopoietic stem cell transplantation
Authors: Bruno, B Gooley, T Sullivan, KM Davis, C Bensinger, WI Storb, R Nash, RA
Citation: B. Bruno et al., Secondary failure of platelet recovery after hematopoietic stem cell transplantation, BIOL BLOOD, 7(3), 2001, pp. 154-162
Hypocalcemia: A pervasive metabolic abnormality in the critically ill
Authors: Zivin, JR Gooley, T Zager, RA Ryan, MJ
Citation: Jr. Zivin et al., Hypocalcemia: A pervasive metabolic abnormality in the critically ill, AM J KIDNEY, 37(4), 2001, pp. 689-698
Trafficking of CD34(+) cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis
Authors: Rowley, SD Yu, J Gooley, T Heimfeld, S Holmberg, L Maloney, D Bensinger, WI
Citation: Sd. Rowley et al., Trafficking of CD34(+) cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis, BONE MAR TR, 28(7), 2001, pp. 649-656
The biological significance of HLA-DP gene variation in haematopoietic cell transplantation
Authors: Petersdorf, EW Gooley, T Malkki, M Anasetti, C Martin, P Woolfrey, A Smith, A Mickelson, E Hansen, JA
Citation: Ew. Petersdorf et al., The biological significance of HLA-DP gene variation in haematopoietic cell transplantation, BR J HAEM, 112(4), 2001, pp. 988-994
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia
Authors: Jurado, M Deeg, HJ Gooley, T Anasetti, C Chauncey, T Flowers, MED Myerson, D Storb, R Appelbaum, FR
Citation: M. Jurado et al., Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia, BR J HAEM, 112(2), 2001, pp. 392-396
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation
Authors: Radich, JP Gooley, T Bryant, E Chauncey, T Clift, R Beppu, L Edmands, S Flowers, MED Kerkof, K Nelson, R Appelbaum, FR
Citation: Jp. Radich et al., The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation, BLOOD, 98(6), 2001, pp. 1701-1707
Response: Statistical designs for clinical trials of radioimmunotherapy
Authors: Gooley, T Storer, B Press, OW
Citation: T. Gooley et al., Response: Statistical designs for clinical trials of radioimmunotherapy, BLOOD, 98(4), 2001, pp. 1276-1276
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
Authors: Nichols, WG Corey, L Gooley, T Davis, C Boeckh, M
Citation: Wg. Nichols et al., Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome, BLOOD, 98(3), 2001, pp. 573-578
Decreased transfusion requirements for patients receiving nonmyeloablativecompared with conventional peripheral blood stem cell transplants from HLA-identical siblings
Authors: Weissinger, F Sandmaier, BM Maloney, DG Bensinger, WI Gooley, T Storb, R
Citation: F. Weissinger et al., Decreased transfusion requirements for patients receiving nonmyeloablativecompared with conventional peripheral blood stem cell transplants from HLA-identical siblings, BLOOD, 98(13), 2001, pp. 3584-3588
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial
Authors: Kansu, E Gooley, T Flowers, MED Anasetti, C Deeg, HJ Nash, RA Sanders, JE Witherspoon, RP Appelbaum, FR Storb, R Martin, PJ
Citation: E. Kansu et al., Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial, BLOOD, 98(13), 2001, pp. 3868-3870
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation
Authors: Zaucha, JM Gooley, T Bensinger, WI Heimfeld, S Chauncey, TR Zaucha, R Martin, PJ Flowers, MED Storek, J Georges, G Storb, R Torok-Storb, B
Citation: Jm. Zaucha et al., CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation, BLOOD, 98(12), 2001, pp. 3221-3227
Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes
Authors: Georges, GE Storb, R Bruno, B Brodie, SJ Thompson, JD Taranova, AG Zaucha, JM Little, MT Zellmer, E Moore, PF Gooley, T Sale, G Kiem, HP Sandmaier, BM Lyons, RM Nash, RA
Citation: Ge. Georges et al., Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes, BLOOD, 98(12), 2001, pp. 3447-3455
Absence of statistically significant correlation between disparity for theminor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation
Authors: Lin, MT Gooley, T Hansen, JA Tseng, LH Martin, EG Singleton, K Smith, AG Mickelson, E Petersdorf, EW Martin, PJ
Citation: Mt. Lin et al., Absence of statistically significant correlation between disparity for theminor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation, BLOOD, 98(10), 2001, pp. 3172-3173
Splenectomy and hemopoietic stem cell transplantation for myelofibrosis
Authors: Li, ZH Gooley, T Appelbaum, FR Deeg, HJ
Citation: Zh. Li et al., Splenectomy and hemopoietic stem cell transplantation for myelofibrosis, BLOOD, 97(7), 2001, pp. 2180-2181
Rising pp65 antigenemia during preemptive anticytomegalovinus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes
Authors: Nichols, WG Corey, L Gooley, T Drew, WL Miner, R Huang, ML Davis, C Boeckh, M
Citation: Wg. Nichols et al., Rising pp65 antigenemia during preemptive anticytomegalovinus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes, BLOOD, 97(4), 2001, pp. 867-874
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
Authors: Carnevale-Schianca, F Martin, P Sullivan, K Flowers, M Gooley, T Anasetti, C Deeg, J Furlong, T McSweeney, P Storb, R Nash, RA
Citation: F. Carnevale-schianca et al., Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease, BIOL BLOOD, 6(6), 2000, pp. 613-620
Second allogeneic transplantation after failure of first autologous transplantation
Authors: Radich, JP Gooley, T Sanders, JE Anasetti, C Chauncey, T Appelbaum, FR
Citation: Jp. Radich et al., Second allogeneic transplantation after failure of first autologous transplantation, BIOL BLOOD, 6(3), 2000, pp. 272-279
Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome
Authors: Deeg, HJ Beckham, C Loken, MR Bryant, E Lesnikova, M Shulman, HM Gooley, T
Citation: Hj. Deeg et al., Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome, LEUK LYMPH, 37(3-4), 2000, pp. 405
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (R) STn-KLH cancer vaccine
Authors: Holmberg, LA Oparin, DV Gooley, T Lilleby, K Bensinger, W Reddish, MA MacLean, GD Longenecker, BM Sandmaier, BM
Citation: La. Holmberg et al., Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (R) STn-KLH cancer vaccine, BONE MAR TR, 25(12), 2000, pp. 1233-1241
Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors
Authors: Park, JR Slattery, J Gooley, T Hawkins, D Lindsley, K Villablanca, JG Matthay, KK Sanders, JE
Citation: Jr. Park et al., Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors, MED PED ONC, 35(6), 2000, pp. 719-723
Busulfan, melphalan, and thiotepa with or without total marrow irradiationwith hematopoietic stem cell rescue for poor-risk Ewing-sarcoma-family tumors
Authors: Hawkins, D Barnett, T Bensinger, W Gooley, T Sanders, E
Citation: D. Hawkins et al., Busulfan, melphalan, and thiotepa with or without total marrow irradiationwith hematopoietic stem cell rescue for poor-risk Ewing-sarcoma-family tumors, MED PED ONC, 34(5), 2000, pp. 328-337
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells
Authors: Carpenter, PA Pavlovic, S Tso, JY Press, OW Gooley, T Yu, XZ Anasetti, C
Citation: Pa. Carpenter et al., Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells, J IMMUNOL, 165(11), 2000, pp. 6205-6213
Cutting edge: Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA10501: Implications in autoimmunity
Authors: Lambert, NC Evans, PC Hashizumi, TL Maloney, S Gooley, T Furst, DE Nelson, JL
Citation: Nc. Lambert et al., Cutting edge: Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA10501: Implications in autoimmunity, J IMMUNOL, 164(11), 2000, pp. 5545-5548
Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation
Authors: Zang, DY Deeg, HJ Gooley, T Anderson, JE Anasetti, C Sanders, J Myerson, D Storb, R Appelbaum, F
Citation: Dy. Zang et al., Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation, BR J HAEM, 110(1), 2000, pp. 217-222
Risultati: 1-25 | 26-35